An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
Findings support model in which accelerated biological aging of mammary epithelia may underpin breast cancer susceptibility ...
PanGIA Biotech, Inc. ("PanGIA Biotech" or "Company") announced that two research abstracts have been accepted for presentation at the American Association for Cancer Research ("AACR") Annual Meeting ...
Researchers at City of Hope, a cancer research and treatment organization, and the University of California, Berkeley, have ...
The United States Food and Drug Administration (FDA) issued guidance on its “Breakthrough Devices Program” in 2023. The ...
Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...
TOBY, Inc., a biotechnology company developing non-invasive cancer screening technologies, today announced that the U.S. Food ...
This predictive model built on readily acquired clinical data provides encouraging results for the detection of residual disease. External validation and prospective studies implementing the model in ...
Live Science on MSN
New blood test aims to spot liver scarring before it paves the way to cancer
Liver scarring can pave the way to cancer down the line. A new blood test in development might help doctors spot it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results